These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Cutaneous anaplastic large-cell lymphoma should be evaluated for systemic involvement regardless of ALK-1 status: case reports and review of literature. Yang S; Khera P; Wahlgren C; Ho J; Jukic D; Geskin L; English JC Am J Clin Dermatol; 2011 Jun; 12(3):203-9. PubMed ID: 21366363 [TBL] [Abstract][Full Text] [Related]
15. Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma? Fornari A; Piva R; Chiarle R; Novero D; Inghirami G Hematol Oncol; 2009 Dec; 27(4):161-70. PubMed ID: 19358142 [TBL] [Abstract][Full Text] [Related]
16. Recurrent ALK-negative anaplastic large T-cell lymphoma presenting as necrotizing vasculitis. Nambudiri VE; Aboutalebi A; Granter SR; Saavedra A Am J Dermatopathol; 2013 Jun; 35(4):512-6. PubMed ID: 23291583 [TBL] [Abstract][Full Text] [Related]
17. Lymphohistiocytic anaplastic large cell lymphoma involving skin: a diagnostic challenge. Chuang SS; Hsieh YC; Ye H; Hwang WS Pathol Res Pract; 2009; 205(4):283-7. PubMed ID: 19091487 [TBL] [Abstract][Full Text] [Related]
18. Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration. Marschalkó M; Eros N; Holló P; Hársing J; Bottlik G; Bátai A; Csukly Z; Masszi T; Szentirmai Z; Fodor J; Kárpáti S; Matolcsy A; Csomor J Am J Dermatopathol; 2010 Oct; 32(7):708-12. PubMed ID: 20644462 [TBL] [Abstract][Full Text] [Related]